QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NASDAQ:NAII

Natural Alternatives International (NAII) Stock Price, News & Analysis

$6.68
+0.12 (+1.83%)
(As of 04:37 PM ET)
Today's Range
$6.68
$6.68
50-Day Range
$5.66
$6.86
52-Week Range
$5.06
$9.44
Volume
415 shs
Average Volume
5,276 shs
Market Capitalization
$40.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NAII stock logo

About Natural Alternatives International Stock (NASDAQ:NAII)

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. The company was founded in 1980 and is headquartered in Carlsbad, California.

NAII Stock Price History

NAII Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Natural Alternatives International Inc NAII
NAII Natural Alternatives International, Inc.
See More Headlines
Receive NAII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Natural Alternatives International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/13/2024
Today
4/19/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
NASDAQ:NAII
Employees
317
Year Founded
N/A

Profitability

Net Income
$2.52 million
Pretax Margin
-3.73%

Debt

Sales & Book Value

Annual Sales
$154.01 million
Cash Flow
$1.13 per share
Book Value
$14.70 per share

Miscellaneous

Free Float
4,835,000
Market Cap
$39.95 million
Optionable
Not Optionable
Beta
0.58
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

NAII Stock Analysis - Frequently Asked Questions

How have NAII shares performed in 2024?

Natural Alternatives International's stock was trading at $6.53 at the beginning of 2024. Since then, NAII stock has increased by 0.5% and is now trading at $6.56.
View the best growth stocks for 2024 here
.

When is Natural Alternatives International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our NAII earnings forecast
.

How were Natural Alternatives International's earnings last quarter?

Natural Alternatives International, Inc. (NASDAQ:NAII) issued its quarterly earnings data on Tuesday, February, 13th. The company reported ($0.52) earnings per share (EPS) for the quarter. The business had revenue of $25.20 million for the quarter. Natural Alternatives International had a negative net margin of 3.22% and a negative trailing twelve-month return on equity of 4.70%.

What is Mark A. LeDoux's approval rating as Natural Alternatives International's CEO?

8 employees have rated Natural Alternatives International Chief Executive Officer Mark A. LeDoux on Glassdoor.com. Mark A. LeDoux has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Natural Alternatives International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Natural Alternatives International investors own include Ascent Solar Technologies (ASTI), LightPath Technologies (LPTH), AbbVie (ABBV), Canadian Solar (CSIQ), BJ's Wholesale Club (BJ), Carnival Co. & (CCL), CV Sciences (CVSI), Amicus Therapeutics (FOLD) and Gilead Sciences (GILD).

How do I buy shares of Natural Alternatives International?

Shares of NAII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NAII) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners